Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6034267A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Dec 5, 1997 |
| Grant date | Mar 7, 2000 |
| Priority date | — |
| Expiry date | Dec 5, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/145555
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a pharmaceutical compositions comprising a compound of formula I: EQU R.sub.2.sup.2 N--CH.sub.2 COCH.sub.2 --CH.sub.2 CO--OR.sup.1(I) wherein, R.sup.1 and R.sup.2 have any of the values defined in the specification; or a salt thereof; and a pharmaceutically acceptable carrier or excipient. The invention also provides a method for the diagnosis or photochemotherapeutic treatment of disorders or abnormalities of external or internal surfaces of the body using such compounds or salts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.